Clinical Trials

Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 116
  • Start Date: September 4, 2021
A Phase II Study of AMG 510 in Participants With Previously Treated Stage IV or Recurrent KRAS G12C Mutated Non-Squamous Non-Small Cell Lung Cancer (ECOG-ACRIN LUNG-MAP SUB-STUDY)
Search for trials
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 3
  • Intervention Type: Dietary Supplement, Drug
  • Participants: 560
  • Start Date: June 2021
A Randomized, Open-Label, Phase 3 Study of Cosibelimab (CK-301) in Combination With Platinum+Pemetrexed Chemotherapy in Subjects With First-Line Metastatic Non-squamous Non-Small Cell Lung Cancer
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 1/Phase 2
  • Intervention Type: Drug, Biological
  • Participants: 100
  • Start Date: June 2021
A Phase 1/2 Open-Label, Dose-escalation and Clinical Response Study of GPX-001 in Combination With Osimertinib in Patients With Advanced, Metastatic EGFR-mutant Non-small Cell Lung Cancer
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Other, Behavioral
  • Participants: 10
  • Start Date: May 15, 2021
Feasibility of a Perioperative Physical Activity Intervention for Older Adults With Lung Cancer and Their Family Caregivers
Showing 1-12 of 1485